The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists
Open accessAbstract
Inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis, are chronic, progressive, immune-mediated diseases of adults and children that have no cure. IBD can cause significant morbidity and lead to complications such as strictures, fistulas, infections, and cancer. In children, IBD can also result in growth impairment and pubertal delays. IBD is highly heterogenous, with severity ranging from mild to severe and symptoms ranging from mild to debilitating. Delay in IBD diagnosis, especially in Crohn’s disease, is common and associated with adverse outcomes. Early diagnosis and prompt institution of treatment are the cornerstones for improving outcomes and maximizing health. Early diagnosis requires a low threshold of suspicion and red flags to guide early specialist referral at the primary provider level. Although the armamentarium of IBD medications is growing, many patients will not respond to treatment, and the selection of first-line therapy is critical. Risk stratification of disease severity, based on clinical, demographic, and serologic markers, can help guide selection of first-line therapy. Clinical decision support tools, genomics, and other biomarkers of response to therapy and risk of adverse events are the future of personalized medicine. After starting appropriate therapy, it is important to confirm remission using objective end points (treat to target) with continued control of inflammation with adjustment of therapy using surrogate biomarkers (tight control). Lastly, IBD therapy extends far beyond medications, and other aspects of the overall health and wellbeing of the patient are critical. These include preventive health, nutrition, and psychobehavioral support addressing patients’ concerns around complementary therapy and medication adherence, prevention of disability, and ensuring open communication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decision aids for people facing health treatment or screening decisions
Stacey, D., Légaré, F., Lewis, K., Barry, M. J., Bennett, C. L., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Thomson, R., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub5 · Cited by 6,685
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Self-citationA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Self-citationC-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J. F., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,143
Self-citationFord Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,020
Khera, A. V., Chaffin, M., Aragam, K. G., Haas, M. E., Roselli, C., Choi, S. H., Natarajan, P., Lander, E. S., Lubitz, S. A., Ellinor, P. T., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0183-z · Cited by 2,953
Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.031 · Cited by 2,911
Self-citationVedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Self-citationTorres, J., Mehandru, S., Colombel, J.-F., & Peyrin-Biroulet, L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31711-1 · Cited by 2,682
Self-citationLiu, J. Z., van Sommeren, S., Huang, H., Ng, S. C., Alberts, R., Takahashi, A., Ripke, S., Lee, J. C., Jostins, L., Shah, T., et al. (2015) · Nature Genetics · doi:10.1038/ng.3359 · Cited by 2,603
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., D'Haens, G., Dotan, I., Dubinsky, M., Feagan, B., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.233 · Cited by 1,844
Self-citationMaaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., Calabrese, E., Baumgart, D. C., Bettenworth, D., Borralho Nunes, P., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy113 · Cited by 1,823
ACG Clinical Guideline: Ulcerative Colitis in Adults
Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000152 · Cited by 1,577
Decision aids for people facing health treatment or screening decisions
Stacey, D., Légaré, F., Col, N. F., Bennett, C. L., Barry, M. J., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Thomson, R., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub4 · Cited by 1,471
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2018.27 · Cited by 1,421
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
Rutter, M., Saunders, B., Wilkinson, K., Rumbles, S., Schofield, G., Kamm, M., Williams, C., Price, A., Talbot, I., & Forbes, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.010 · Cited by 1,255
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Sands, B. E., Sandborn, W. J., Panaccione, R., O’Brien, C. D., Zhang, H., Johanns, J., Adedokun, O. J., Li, K., Peyrin-Biroulet, L., Van Assche, G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1900750 · Cited by 1,219
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease
Ruemmele, F. M., Veres, G., Kolho, K. L., Griffiths, A., Levine, A., Escher, J. C., Amil Dias, J., Barabino, A., Braegger, C. P., Bronsky, J., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.04.005 · Cited by 1,083
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Peyrin-Biroulet, L., Loftus, E. V., Colombel, J.-F., & Sandborn, W. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.579 · Cited by 1,047
Self-citationDubinsky, M. C., Lamothe, S., Yang, H. Y., Targan, S. R., Sinnett, D., Théorêt, Y., & Seidman, E. G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70140-5 · Cited by 996
Panaccione, R., Ghosh, S., Middleton, S., Márquez, J. R., Scott, B. B., Flint, L., van Hoogstraten, H. J. F., Chen, A. C., Zheng, H., Danese, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.052 · Cited by 963
Colombel, J.-F., Panaccione, R., Bossuyt, P., Lukas, M., Baert, F., Vaňásek, T., Danalioglu, A., Novacek, G., Armuzzi, A., Hébuterne, X., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32641-7 · Cited by 921
Self-citationFrolkis, A. D., Dykeman, J., Negrón, M. E., deBruyn, J., Jette, N., Fiest, K. M., Frolkis, T., Barkema, H. W., Rioux, K. P., Panaccione, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.041 · Cited by 892
Beaugerie, L., Seksik, P., Nion–Larmurier, I., Gendre, J., & Cosnes, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.019 · Cited by 860
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study
Bernstein, C. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02319-x · Cited by 815
Thia, K. T., Sandborn, W. J., Harmsen, W. S., Zinsmeister, A. R., & Loftus, E. V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.070 · Cited by 792
Cleynen, I., Boucher, G., Jostins, L., Schumm, L. P., Zeissig, S., Ahmad, T., Andersen, V., Andrews, J. M., Annese, V., Brand, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00465-1 · Cited by 779
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Sands, B. E., Peyrin-Biroulet, L., Loftus, E. V., Danese, S., Colombel, J.-F., Törüner, M., Jonaitis, L., Abhyankar, B., Chen, J., Rogers, R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905725 · Cited by 754
Self-citationSolberg, I. C., Lygren, I., Jahnsen, J., Aadland, E., Høie, O., Cvancarova, M., Bernklev, T., Henriksen, M., Sauar, J., Vatn, M. H., et al. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802600961 · Cited by 731
AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis
Feuerstein, J. D., Isaacs, K. L., Schneider, Y., Siddique, S. M., Falck-Ytter, Y., Singh, S., Chachu, K., Day, L., Lebwohl, B., Muniraj, T., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.006 · Cited by 713
Levine, A., Wine, E., Assa, A., Sigall Boneh, R., Shaoul, R., Kori, M., Cohen, S., Peleg, S., Shamaly, H., On, A., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.021 · Cited by 671
Kugathasan, S., Denson, L. A., Walters, T. D., Kim, M.-O., Marigorta, U. M., Schirmer, M., Mondal, K., Liu, C., Griffiths, A., Noe, J. D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30317-3 · Cited by 633
Vavricka, S. R., Brun, L., Ballabeni, P., Pittet, V., Vavricka, B. M. P., Zeitz, J., Rogler, G., & Schoepfer, A. M. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.343 · Cited by 592
Development of the Crohnʼs disease digestive damage score, the Lémann score
Pariente, B., Cosnes, J., Danese, S., Sandborn, W. J., Lewin, M., Fletcher, J. G., Chowers, Y., DʼHaens, G., Feagan, B. G., Hibi, T., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21506 · Cited by 588
Self-citationFeuerstein, J. D., Nguyen, G. C., Kupfer, S. S., Falck-Ytter, Y., Singh, S., Gerson, L., Hirano, I., Nguyen, G. C., Rubenstein, J. H., Smalley, W. E., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.032 · Cited by 576
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Vavricka, S. R., Bruegger, L. E., & Seibold, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.545 · Cited by 570
Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000620 · Cited by 567
Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review
Fumery, M., Singh, S., Dulai, P. S., Gower-Rousseau, C., Peyrin-Biroulet, L., & Sandborn, W. J. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.06.016 · Cited by 500
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
Moriyama, T., Nishii, R., Perez-Andreu, V., Yang, W., Klussmann, F. A., Zhao, X., Lin, T.-N., Hoshitsuki, K., Nersting, J., Kihira, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3508 · Cited by 477
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473
Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data
Coward, S., Clement, F., Benchimol, E. I., Bernstein, C. N., Avina-Zubieta, J. A., Bitton, A., Carroll, M. W., Hazlewood, G., Jacobson, K., Jelinski, S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.002 · Cited by 449
Brandse, J. F., van den Brink, G. R., Wildenberg, M. E., van der Kleij, D., Rispens, T., Jansen, J. M., Mathôt, R. A., Ponsioen, C. Y., Löwenberg, M., & D’Haens, G. R. A. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.016 · Cited by 433
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation
Park, K. T., Ehrlich, O. G., Allen, J. I., Meadows, P., Szigethy, E. M., Henrichsen, K., Kim, S. C., Lawton, R. C., Murphy, S. M., Regueiro, M., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz104 · Cited by 431
Cellier, C., Sahmoud, T., Froguel, E., Adenis, A., Belaiche, J., Bretagne, J. F., Florent, C., Bouvry, M., Mary, J. Y., & Modigliani, R. (1994) · Gut · doi:10.1136/gut.35.2.231 · Cited by 430
Sazonovs, A., Kennedy, N. A., Moutsianas, L., Heap, G. A., Rice, D. L., Reppell, M., Bewshea, C. M., Chanchlani, N., Walker, G. J., Perry, M. H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.09.041 · Cited by 423
Enteral Nutrition and Corticosteroids in the Treatment of Acute Crohn's Disease in Children
Heuschkel, R. B., Menache, C. C., Megerian, T. J., & Baird, A. E. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2000.tb02821.x · Cited by 412
Menees, S. B., Powell, C., Kurlander, J., Goel, A., & Chey, W. D. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.6 · Cited by 391
Singh, S., Murad, M. H., Fumery, M., Dulai, P. S., & Sandborn, W. J. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.01.008 · Cited by 375
Ordás, I., Rimola, J., Rodríguez, S., Paredes, J. M., Martínez-Pérez, M. J., Blanc, E., Arévalo, J. A., Aduna, M., Andreu, M., Radosevic, A., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.055 · Cited by 368
Ponsioen, C. Y., de Groof, E. J., Eshuis, E. J., Gardenbroek, T. J., Bossuyt, P. M. M., Hart, A., Warusavitarne, J., Buskens, C. J., van Bodegraven, A. A., Brink, M. A., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30248-0 · Cited by 367
de Jong, M. J., van der Meulen-de Jong, A. E., Romberg-Camps, M. J., Becx, M. C., Maljaars, J. P., Cilissen, M., van Bodegraven, A. A., Mahmmod, N., Markus, T., Hameeteman, W. M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31327-2 · Cited by 350
Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy
Panés, J., & Rimola, J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.104 · Cited by 308
Growth failure in children with inflammatory bowel disease: A prospective study
Motil, K. J., Grand, R. J., Davis-Kraft, L., Ferlic, L. L., & Smith, E. O. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90883-e · Cited by 299
Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
Torres, J., Billioud, V., Sachar, D. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22839 · Cited by 296
Self-citationTreat to Target: A Proposed New Paradigm for the Management of Crohn's Disease
Bouguen, G., Levesque, B. G., Feagan, B. G., Kavanaugh, A., Peyrin–Biroulet, L., Colombel, J., Hanauer, S. B., & Sandborn, W. J. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.006 · Cited by 294
Self-citationSchoepfer, A. M., Beglinger, C., Straumann, A., Safroneeva, E., Romero, Y., Armstrong, D., Schmidt, C., Trummler, M., Pittet, V., & Vavricka, S. R. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182810066 · Cited by 294
Mao, R., Xiao, Y.-L., Gao, X., Chen, B.-L., He, Y., Yang, L., Hu, P.-J., & Chen, M.-H. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22861 · Cited by 280
Growth and clinical course of children with Crohn's disease.
Griffiths, A. M., Nguyen, P., Smith, C., MacMillan, J. H., & Sherman, P. M. (1993) · Gut · doi:10.1136/gut.34.7.939 · Cited by 272
Meta‐analysis: enteral nutrition in active Crohn’s disease in children
DZIECHCIARZ, P., HORVATH, A., SHAMIR, R., & SZAJEWSKA, H. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03431.x · Cited by 258
Predictors of response to infliximab in patients with Crohn's disease
Parsi, M. A., Achkar, J., Richardson, S., Katz, J., Hammel, J. P., Lashner, B. A., & Brzezinski, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.35390 · Cited by 252
Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity
Kucharzik, T., Wittig, B. M., Helwig, U., Börner, N., Rössler, A., Rath, S., Maaser, C., Naumann, A., Pelster, G., Spengler, J., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.10.040 · Cited by 250
Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease
Ungaro, R. C., Yzet, C., Bossuyt, P., Baert, F. J., Vanasek, T., D’Haens, G. R., Joustra, V. W., Panaccione, R., Novacek, G., Reinisch, W., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.039 · Cited by 241
Self-citationOuahed, J., Spencer, E., Kotlarz, D., Shouval, D. S., Kowalik, M., Peng, K., Field, M., Grushkin-Lerner, L., Pai, S.-Y., Bousvaros, A., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz259 · Cited by 220
Self-citationGuellouz, S., Pariente, B., Benet, C., Baudry, C., Lourenco, N., Kraemer, A., Allez, M., & Gornet, J.-M. (2014) · Case Reports in Gastroenterology · doi:10.1159/000360844 · Cited by 216
Lasson, A., Stotzer, P.-O., Öhman, L., Isaksson, S., Sapnara, M., & Strid, H. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.06.002 · Cited by 211
Maaser, C., Petersen, F., Helwig, U., Fischer, I., Roessler, A., Rath, S., Lang, D., & Kucharzik, T. (2020) · Gut · doi:10.1136/gutjnl-2019-319451 · Cited by 208
Singh, S., Fumery, M., Sandborn, W. J., & Murad, M. H. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14852 · Cited by 199
Langhorst, J., Wulfert, H., Lauche, R., Klose, P., Cramer, H., Dobos, G. J., & Korzenik, J. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jju007 · Cited by 198
International Serious Adverse Events Consortium, Heap, G. A., IBD Pharmacogenetics Study Group, Weedon, M. N., Bewshea, C. M., Singh, A., Chen, M., Satchwell, J. B., Vivian, J. P., So, K., et al. (2014) · Nature Genetics · doi:10.1038/ng.3093 · Cited by 190
Ananthakrishnan, A. N., Shi, H. Y., Tang, W., Law, C. C. Y., Sung, J. J. Y., Chan, F. K. L., & Ng, S. C. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw054 · Cited by 168
Use of exclusive enteral nutrition in adults with Crohn’s disease: A review
Wall, C. L., Day, A. S., & Gearry, R. B. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i43.7652 · Cited by 165
Dulai, P. S., Boland, B. S., Singh, S., Chaudrey, K., Koliani‐Pace, J. L., Kochhar, G. S., Parikh, M. P., Shmidt, E., Hartke, J. G., Chilukuri, P., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.039 · Cited by 164
Self-citationPredicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases
Torres, J., Caprioli, F., Katsanos, K. H., Lobatón, T., Micić, D., Zerôncio, M., Assche, G. V., Lee, J. C., Lindsay, J. O., Rubin, D. T., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw116 · Cited by 162
Self-citationDevelopment of an index to define overall disease severity in IBD
Siegel, C. A., Whitman, C. B., Spiegel, B. M. R., Feagan, B. G., Sands, B. E., Loftus, E. V., Panaccione, R., D’Haens, G., Bernstein, C. N., Gearry, R. B., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312648 · Cited by 151
Self-citationDiet in Treatment of Inflammatory Bowel Diseases
Sasson, A. N., Ananthakrishnan, A. N., & Raman, M. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.054 · Cited by 150
Han, X., Uchida, K., Jurickova, I., Koch, D. E., Willson, T. A., Samson, C. M., Bonkowski, E. L., Trauernicht, A. K., Kim, M., Tomer, G., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.12.046 · Cited by 143
Ng, S. C., Leung, W. K., Shi, H. Y., Li, M. K. K., Leung, C. M., Ng, C. K. M., Lo, F. H., Hui, Y. T., Tsang, S., Chan, Y. K., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000846 · Cited by 138
Kochar, B. D., Cai, W., Cagan, A., & Ananthakrishnan, A. N. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.032 · Cited by 138
Health Supervision in the Management of Children and Adolescents With IBD: NASPGHAN Recommendations
Rufo, P. A., Denson, L. A., Sylvester, F. A., Szigethy, E., Sathya, P., Lu, Y., Wahbeh, G. T., Sena, L. M., & Faubion, W. A. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31825959b8 · Cited by 129
Siegel, C. A., Horton, H. A., Siegel, L. S., Thompson, K. D., MacKenzie, T. A., Stewart, S. K., Rice, P. W., Stempak, J. M., Dezfoli, S., Haritunians, T., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13460 · Cited by 129
Danese, S., Fiorino, G., Mary, J., Lakatos, P. L., D’Haens, G., Moja, L., D’Hoore, A. J. L., Panés, J., Reinisch, W., Sandborn, W. J., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv067 · Cited by 121
Self-citationGender Differences in Presentation and Course of Disease in Pediatric Patients With Crohn Disease
Gupta, N., Bostrom, A., Kirschner, B. S., Ferry, G. D., Winter, H. S., Baldassano, R. N., Gold, B. D., Abramson, O., Smith, T., Cohen, S. A., et al. (2007) · PEDIATRICS · doi:10.1542/peds.2007-0905 · Cited by 121
Bessissow, T., Le, N. H., Rollet, K., Afif, W., Bitton, A., & Sebastiani, G. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000832 · Cited by 117
Severs, M., Spekhorst, L. M., Mangen, M.-J. J., Dijkstra, G. D. H., Löwenberg, M., Hoentjen, F., Jong, A. E. V. D. M., Pierik, M. J., Ponsioen, C. Y., Bouma, G., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy004 · Cited by 107
de Groof, E. J., Stevens, T. W., Eshuis, E. J., Gardenbroek, T. J., Bosmans, J. E., van Dongen, J. M., Mol, B., Buskens, C. J., Stokkers, P. C. F., Hart, A. L., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317539 · Cited by 106
Burisch, J. M., Jess, T., & Egeberg, A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.03.040 · Cited by 105
Schaeffeler, E., Jaeger, S. U., Klumpp, V., Yang, J. J. J., Igel, S., Hinze, L., Stanulla, M., & Schwab, M. G. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0448-7 · Cited by 104
Regueiro, M. D., Click, B. H., Anderson, A. J. M., Shrank, W. H., Kogan, J. N., McAnallen, S., & Szigethy, E. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.007 · Cited by 100
Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
Osterman, M. T., Aberra, F. N., Cross, R. K., Liakos, S., McCabe, R. P., Shafran, I., Wolf, D. C., Hardi, R., Nessel, L. A., Brensinger, C. M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.03.035 · Cited by 96
Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease
Kennedy, N. A., Jones, G., Plevris, N., Pattenden, R. J., Arnott, I. D., & Lees, C. W. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.02.017 · Cited by 91
Dulai, P. S., Singh, S., Casteele, N. V., Meserve, J. D., Winters, A. C., Chablaney, S., Aniwan, S., Shashi, P., Kochhar, G. S., Weiss, A., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.010 · Cited by 89
Self-citationD’Haens, G., Kelly, O., Battat, R. J., Silverberg, M. S., Laharie, D., Louis, E. J., Savarino, E. V., Bodini, G., Yarur, A. J., Boland, B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.10.034 · Cited by 88
Selby, L. A., Kane, S. V., Wilson, J., Balla, P., Riff, B. P., Bingcang, C. M., Hoellein, A. R., Pande, S., & de Villiers, W. J. S. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20266 · Cited by 85
Sehgal, P., Ungaro, R. C., Foltz, C., Iacoviello, B., Dubinsky, M. C., & Keefer, L. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa196 · Cited by 82
Self-citationGuidi, L., Pugliese, D., Tonucci, T. P., Berrino, A., Tolusso, B., Basile, M., Cantoro, L., Balestrieri, P., Civitelli, F. S., Bertani, L., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy076 · Cited by 81
Damas, O. M., Garces, L. C., & Abreu, M. T. (2019) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-019-00231-8 · Cited by 80
Frivolt, K., Schwerd, T., Werkstetter, K. J., Schwarzer, A., Schatz, S. B., Bufler, P., & Koletzko, S. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12770 · Cited by 79
Limketkai, B. N., Shah, S. C., Hirano, I., Bellaguarda, E., & Colombel, J. (2019) · Gut · doi:10.1136/gutjnl-2018-318074 · Cited by 77
Self-citationBlackwell, J., Saxena, S. K., Jayasooriya, N., Bottle, A., Petersen, I., Hotopf, M. H., Alexakis, C., & Pollok, R. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa146 · Cited by 76
Faye, A. S., Wen, T., Soroush, A., Ananthakrishnan, A. N., Ungaro, R. C., Lawlor, G. O., Attenello, F. J., Mack, W. J., Colombel, J., & Lebwohl, B. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06746-w · Cited by 76
Self-citationCrohn's disease in the over-60 age group
Heresbach, D., Alexandre, J.-L., Bretagne, J., et al. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000108337.41221.08 · Cited by 74
Granulocyte–Macrophage Colony-Stimulating Factor Autoantibodies
Gathungu, G. N., Kim, M., Ferguson, J. P., Sharma, Y., Zhang, W., Ng, S. M. E., Bonkowski, E. L., Ning, K., Simms, L. A., Croft, A. R., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f506 · Cited by 73
Zhao, M., Lo, B. Z. S., Vester-Andersen, M. K., Vind, I., Bendtsen, F., & Burisch, J. M. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy374 · Cited by 71
Targownik, L. E., Benchimol, E. I., Bernstein, C. N., Singh, H., Tennakoon, A., Zubieta, A. A., Coward, S., Jones, J., Kaplan, G. G., Kuenzig, M. E., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa050 · Cited by 71
Ungaro, R. C., Limketkai, B. N., Jensen, C. B., Allin, K. H., Agrawal, M., Ullman, T. A., Colombel, J., & Jess, T. (2018) · Gut · doi:10.1136/gutjnl-2018-317021 · Cited by 69
Self-citationvan Gennep, S., Evers, S. W., Rietdijk, S. T., Gielen, M. E., de Boer, N. K. H., Gecse, K. B., Ponsioen, C. Y., Duijvestein, M., D’Haens, G., de Boer, A. G. E. M., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa082 · Cited by 66
Burisch, J. M., Ungaro, R. C., Vind, I., Prosberg, M. V., Bendtsen, F., Colombel, J., & Vester-Andersen, M. K. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx066 · Cited by 63
Self-citationSex differences in statural growth impairment in Crohnʼs disease: Role of IGF-1
Gupta, N., Lustig, R. H., Kohn, M. A., McCracken, M. F., & Vittinghoff, E. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21617 · Cited by 62
Walker, D. G., Williams, H. R. T., Kane, S. P., Mawdsley, J. E. D., Arnold, J., McNeil, I., Thomas, H. J. W., TEARE, J. P., Hart, A. L., Pitcher, M., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.85 · Cited by 58
Chateau, T., Bonovas, S., Berre, C. L., Mathieu, N., Danese, S., & Peyrin‐Biroulet, L. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz095 · Cited by 57
Tiao, D. K., Chan, W. P. W., Jeganathan, J., Chan, J., Perry, J., Selinger, C. P., & Leong, R. W. L. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001194 · Cited by 56
Bucalo, A., Rega, F., Zangrilli, A., Silvestri, V., Valentini, V., Scafetta, G., Marraffa, F., Grassi, S., Rogante, E., Piccolo, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217873 · Cited by 50
Rodríguez–Lago, I., del Hoyo, J., Pérez‐Girbés, A., Garrido‐Marín, A., Casanova, M. J., Chaparro, M., Fernandez-Clotet, A., Castro‐Poceiro, J., García, M. J., Sánchez, S., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620947579 · Cited by 48
Nahon, S., Lahmek, P., Paupard, T., Lesgourgues, B., Chaussade, S., Peyrin‐Biroulet, L., & Abitbol, V. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4189-z · Cited by 47
Plevris, N., Fulforth, J. M., Lyons, M., Siakavellas, S. I., Jenkinson, P. W., Chuah, C. S., Lucaciu, L., Pattenden, R. J., Arnott, I. D., Jones, G., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.08.022 · Cited by 46
Burden of Crohn’s disease in the United States: long-term healthcare and work-loss related costs
Manceur, A. M., Ding, Z., Muser, E., Obando, C., Voelker, J., Pilon, D., Kinkead, F., Lafeuille, M., & Lefèbvre, P. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2020.1789649 · Cited by 45
Communication Between Physicians and Patients with Ulcerative Colitis
Rubin, D. T., Dubinsky, M. C., Martino, S., Hewett, K. A., & Panés, J. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001048 · Cited by 43
Mikocka-Walus, A. A., Turnbull, D., Holtmann, G., & Andrews, J. M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22850 · Cited by 41
Agrawal, M., Burisch, J. M., Colombel, J., & Shah, S. C. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz139 · Cited by 41
Self-citationFiorino, G., Bonovas, S., Gilardi, D., Sabatino, A. D., Allocca, M., Furfaro, F., Roda, G., Lenti, M. V., Aronico, N., Mengoli, C., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa111 · Cited by 41
Doherty, R. P., Liao, H., Satsangi, J. J., & Ternette, N. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.073 · Cited by 38
Calprotectin instability may lead to undertreatment in children with IBD
Haisma, S., van Rheenen, P. F., Wagenmakers-Huizenga, L. M. F., & Kobold, A. C. M. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2018-316584 · Cited by 36
Vadstrup, K., Alulis, S., Borsi, A., Gustafsson, N., Nielsen, A. H., Wennerström, C., Jørgensen, T. R., Qvist, N., & Munkholm, P. S. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz265 · Cited by 36
Quality improvement project identifies factors associated with delay in IBD diagnosis
Walker, G., Lin, S., Chanchlani, N., Thomas, A., Hendy, P. J., Heerasing, N. M., Moore, L., Green, H., Chee, D., Bewshea, C., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15885 · Cited by 35
Inflammatory Bowel Diseases and School Absenteeism
Eloi, C., Foulon, G., Bridoux‐Henno, L., Breton, E., Pelatan, C., Chaillou, E., Grimal, I., Darviot, E., Carré, E., Gastineau, S., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002207 · Cited by 32
Attauabi, M., Zhao, M., Bendtsen, F., & Burisch, J. M. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa167 · Cited by 32
Qiu, Y., Chen, B., Li, Y., Xiong, S., Zhang, S., He, Y., Zeng, Z., Ben‐Horin, S., Chen, M., & Mao, R. (2019) · BMC Gastroenterology · doi:10.1186/s12876-018-0928-2 · Cited by 31
Lester, R. A., Lu, Y., & Tung, J. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000730 · Cited by 25
Laurent, V., Naudé, S., Vuitton, L., Zallot, C., Baumann, C., Girard-Gavanier, M., & Peyrin‐Biroulet, L. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw211 · Cited by 25
Agrawal, M., Bento-Miranda, M., Walsh, S., Narula, N., Colombel, J., & Ungaro, R. C. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab030 · Cited by 25
Self-citationCasteele, N. V., Jairath, V., Jeyarajah, J., Dulai, P. S., Singh, S., Shackelton, L. M., Feagan, B. G., & Sandborn, W. J. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.078 · Cited by 23
Cited by
Wang, R., Li, Z., Liu, S., & Zhang, D. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-065186 · Cited by 597
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
Wangchuk, P., Yeshi, K., & Loukas, A. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.08.003 · Cited by 333
Fan, X., Xia, Q., Zhang, Y., Li, Y., Feng, Z., Zhou, J., Qi, J., Tang, B. Z., Qian, J., & Lin, H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101043 · Cited by 94
Xiao, P., Liang, M., Yang, S., Sun, Y., Li, J., Gu, Z., Zhang, L., Fan, Q., Jiang, X., & Wu, W. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.121993 · Cited by 36
Metadata
- Authors
- Agrawal, M., Spencer, E. A., Colombel, J.-F., & Ungaro, R. C.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 161
- Issue
- 1
- Pages
- 47-65
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W3159293225
- Cited by
- 261
- References
- 137
- FWCI
- 18.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.